Navigation Links
Schmidt & Clark, LLP: FDA Reports Show Abbott Labs Subsidiary Failed to Disclose Parasite Eye Infections Tied to Contact Lens Solution
Date:6/22/2009

WASHINGTON, June 22 /PRNewswire-FirstCall/ -- The Washington, D.C.-based law firm of Schmidt & Clark, LLP, is announcing the results of an inspection conducted by the U.S. Food and Drug Administration where investigators determined that a subsidiary of Abbott Park, Ill.-based Abbott Laboratories Inc. (NYSE: ABT) failed to disclose multiple reports of a serious parasitic eye infection for more than a year.

In an Associated Press story reported June 20, 2009, Schmidt & Clark Managing Partner Michael Schmidt says the documents reveal the link between Acanthamoeba Keratitis and a popular contact lens solution sold by Irvine, Calif.-based Abbott Medical Optics ("AMO"), an Abbott Labs subsidiary.

"It confirms our suspicion that AMO knew, or should have known, that there was a significant increase in Acanthamoeba Keratitis cases associated with Complete MoisturePlus," Mr. Schmidt says in the article.

According to the report obtained under the Freedom of Information Act, inspectors from the FDA discovered that AMO failed to disclose at least nine reported cases of the sight-threatening eye infection Acanthamoeba Keratitis among users of the company's Complete MoisturePlus contact lens solution.

According to the FDA report, AMO began receiving complaints of serious corneal infections in February 2006, but those reports were not disclosed until an FDA inspection in late May and early June 2007. The Centers for Disease Control launched its own investigation after receiving increasing reports of the rare infection.

AMO finally recalled Complete MoisturePlus in May 2007 after the Centers for Disease Control released data showing that users of the product were seven times more likely to be infected with Acanthamoeba Keratitis than those who never used Complete MoisturePlus. The FDA subsequently categorized the withdrawal as a Class I recall, a status reserved for situations where there is a reasonable probability that the recalled product will cause serious health problems or deaths.

Currently, more than 150 former users of Complete MoisturePlus are pursuing injury lawsuits against AMO in Orange County Superior Court, including some victims who have lost sight or suffered eye removal. An undetermined number of people suffered vision loss and eye injuries as result of their use of Complete MoisturePlus. To learn more about Acanthamoeba Keratitis or the Complete MoisturePlus Recall please visit the Schmidt & Clark website at www.schmidtandclark.com.

For more information, please contact Bruce Vincent at 800-559-4534 or bruce@androvett.com.


'/>"/>
SOURCE Schmidt & Clark, LLP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. OPKO Health Appoints Pascal J. Goldschmidt to Board of Directors
2. Sam Schmidt Receives a Honda Odyssey Converted for Wheelchair Accessibility
3. Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men
4. Californian Files Contact Lens Solution False Advertising Class Action Against Advanced Medical Optics, Announces the Schmidt Firm, LLP
5. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
6. Haemacure Reports Third Quarter 2007 Results
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
11. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... , ... Further establishing itself as a leader in natural pet products category, ... were selected from over 1,000 entrants as a winner and recipient of the prestigious ... for dogs are a favorite product among pet-parents worldwide, as each whimsical knobby shape ...
(Date:5/2/2016)... ... May 02, 2016 , ... Zitter Health Insights ... Patient Satisfaction Award that will recognize specialty pharmacies for their achievements in customer ... Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled throughout 2016. Results will be published ...
(Date:5/2/2016)... ... May 02, 2016 , ... Dr. Rassouli, dentist in Orange ... decline. According to the research, which was published in the “Journal of the American ... and about 5.4 million Americans have Alzheimer’s disease. The study found that dental problems ...
(Date:5/2/2016)... ... May 02, 2016 , ... Visceral fat, also known ... the kidneys, liver and pancreas. If not properly addressed, visceral fat can lead ... Internal Medicine, Medical Oncology and Palliative Care, warns against the dangers of visceral ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... The 2016 World Ultimate & Guts Championship ... Camp at Manhattan College, made the cut. The WUGC is being held in London, England ... won the gold in the men’s division, another gold in the women’s masters division, and ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... , May 2, 2016  Deerfield announced ... financing of Graybug Vision, Inc. Graybug Vision is ... therapies that may transform care for ocular diseases ... Graybug Vision,s technology was first developed at Johns ... a startup venture. Graybug Vision ...
(Date:5/2/2016)...  While nearly three-quarters of Americans (71%) are aware ... health, only about half report taking any steps to ... a new survey announced today by Hologic (Nasdaq: ... Osteoporosis Month, Hologic is raising awareness of this major ... Americans. Osteoporosis is a disease that causes ...
(Date:5/2/2016)... May 2, 2016  Celsion Corporation (NASDAQ: ... announced data from the first cohort of patients ... (the OVATION Study) combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  In the first three patients dosed, ...
Breaking Medicine Technology: